710 related articles for article (PubMed ID: 28489825)
1. Intratumoural heterogeneity generated by Notch signalling promotes small-cell lung cancer.
Lim JS; Ibaseta A; Fischer MM; Cancilla B; O'Young G; Cristea S; Luca VC; Yang D; Jahchan NS; Hamard C; Antoine M; Wislez M; Kong C; Cain J; Liu YW; Kapoun AM; Garcia KC; Hoey T; Murriel CL; Sage J
Nature; 2017 May; 545(7654):360-364. PubMed ID: 28489825
[TBL] [Abstract][Full Text] [Related]
2. Molecular pathology of small cell lung cancer: Overview from studies on neuroendocrine differentiation regulated by ASCL1 and Notch signaling.
Ito T
Pathol Int; 2024 May; 74(5):239-251. PubMed ID: 38607250
[TBL] [Abstract][Full Text] [Related]
3. Dll4-Fc, an inhibitor of Dll4-notch signaling, suppresses liver metastasis of small cell lung cancer cells through the downregulation of the NF-κB activity.
Kuramoto T; Goto H; Mitsuhashi A; Tabata S; Ogawa H; Uehara H; Saijo A; Kakiuchi S; Maekawa Y; Yasutomo K; Hanibuchi M; Akiyama S; Sone S; Nishioka Y
Mol Cancer Ther; 2012 Dec; 11(12):2578-87. PubMed ID: 22989420
[TBL] [Abstract][Full Text] [Related]
4. Targeting NOTCH activation in small cell lung cancer through LSD1 inhibition.
Augert A; Eastwood E; Ibrahim AH; Wu N; Grunblatt E; Basom R; Liggitt D; Eaton KD; Martins R; Poirier JT; Rudin CM; Milletti F; Cheng WY; Mack F; MacPherson D
Sci Signal; 2019 Feb; 12(567):. PubMed ID: 30723171
[TBL] [Abstract][Full Text] [Related]
5. Notch pathway in small-cell lung cancer: from preclinical evidence to therapeutic challenges.
Leonetti A; Facchinetti F; Minari R; Cortellini A; Rolfo CD; Giovannetti E; Tiseo M
Cell Oncol (Dordr); 2019 Jun; 42(3):261-273. PubMed ID: 30968324
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive genomic profiles of small cell lung cancer.
George J; Lim JS; Jang SJ; Cun Y; Ozretić L; Kong G; Leenders F; Lu X; Fernández-Cuesta L; Bosco G; Müller C; Dahmen I; Jahchan NS; Park KS; Yang D; Karnezis AN; Vaka D; Torres A; Wang MS; Korbel JO; Menon R; Chun SM; Kim D; Wilkerson M; Hayes N; Engelmann D; Pützer B; Bos M; Michels S; Vlasic I; Seidel D; Pinther B; Schaub P; Becker C; Altmüller J; Yokota J; Kohno T; Iwakawa R; Tsuta K; Noguchi M; Muley T; Hoffmann H; Schnabel PA; Petersen I; Chen Y; Soltermann A; Tischler V; Choi CM; Kim YH; Massion PP; Zou Y; Jovanovic D; Kontic M; Wright GM; Russell PA; Solomon B; Koch I; Lindner M; Muscarella LA; la Torre A; Field JK; Jakopovic M; Knezevic J; Castaños-Vélez E; Roz L; Pastorino U; Brustugun OT; Lund-Iversen M; Thunnissen E; Köhler J; Schuler M; Botling J; Sandelin M; Sanchez-Cespedes M; Salvesen HB; Achter V; Lang U; Bogus M; Schneider PM; Zander T; Ansén S; Hallek M; Wolf J; Vingron M; Yatabe Y; Travis WD; Nürnberg P; Reinhardt C; Perner S; Heukamp L; Büttner R; Haas SA; Brambilla E; Peifer M; Sage J; Thomas RK
Nature; 2015 Aug; 524(7563):47-53. PubMed ID: 26168399
[TBL] [Abstract][Full Text] [Related]
7. Soluble guanylate cyclase signalling mediates etoposide resistance in progressing small cell lung cancer.
Schenk MW; Humphrey S; Hossain ASMM; Revill M; Pearsall S; Lallo A; Brown S; Bratt S; Galvin M; Descamps T; Zhou C; Pearce SP; Priest L; Greenhalgh M; Chaturvedi A; Kerr A; Blackhall F; Dive C; Frese KK
Nat Commun; 2021 Nov; 12(1):6652. PubMed ID: 34789728
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of role of Notch3 signaling pathway in human lung cancer cells.
Hassan WA; Yoshida R; Kudoh S; Motooka Y; Ito T
J Cancer Res Clin Oncol; 2016 May; 142(5):981-93. PubMed ID: 26838758
[TBL] [Abstract][Full Text] [Related]
9. Gamma-secretase inhibitor prevents Notch3 activation and reduces proliferation in human lung cancers.
Konishi J; Kawaguchi KS; Vo H; Haruki N; Gonzalez A; Carbone DP; Dang TP
Cancer Res; 2007 Sep; 67(17):8051-7. PubMed ID: 17804716
[TBL] [Abstract][Full Text] [Related]
10. NOTCH, ASCL1, p53 and RB alterations define an alternative pathway driving neuroendocrine and small cell lung carcinomas.
Meder L; König K; Ozretić L; Schultheis AM; Ueckeroth F; Ade CP; Albus K; Boehm D; Rommerscheidt-Fuss U; Florin A; Buhl T; Hartmann W; Wolf J; Merkelbach-Bruse S; Eilers M; Perner S; Heukamp LC; Buettner R
Int J Cancer; 2016 Feb; 138(4):927-38. PubMed ID: 26340530
[TBL] [Abstract][Full Text] [Related]
11. A conserved YAP/Notch/REST network controls the neuroendocrine cell fate in the lungs.
Shue YT; Drainas AP; Li NY; Pearsall SM; Morgan D; Sinnott-Armstrong N; Hipkins SQ; Coles GL; Lim JS; Oro AE; Simpson KL; Dive C; Sage J
Nat Commun; 2022 May; 13(1):2690. PubMed ID: 35577801
[TBL] [Abstract][Full Text] [Related]
12. Notch1 signaling controls cell proliferation, apoptosis and differentiation in lung carcinoma.
Wael H; Yoshida R; Kudoh S; Hasegawa K; Niimori-Kita K; Ito T
Lung Cancer; 2014 Aug; 85(2):131-40. PubMed ID: 24888228
[TBL] [Abstract][Full Text] [Related]
13. Taking SCLC on a Bad LSD(1) Trip One NOTCH Further.
Kim J; Sage J
Trends Mol Med; 2019 Apr; 25(4):261-264. PubMed ID: 30852141
[TBL] [Abstract][Full Text] [Related]
14. Plasticity in the Absence of NOTCH Uncovers a RUNX2-Dependent Pathway in Small Cell Lung Cancer.
Hong D; Knelson EH; Li Y; Durmaz YT; Gao W; Walton E; Vajdi A; Thai T; Sticco-Ivins M; Sabet AH; Jones KL; Schinzel AC; Bronson RT; Nguyen QD; Tolstorukov MY; Vivero M; Signoretti S; Barbie DA; Oser MG
Cancer Res; 2022 Jan; 82(2):248-263. PubMed ID: 34810201
[TBL] [Abstract][Full Text] [Related]
15. [Dual tumor suppressive and oncogenic roles for Notch signaling in small cell lung cancer].
Oliverio R; Sage J
Med Sci (Paris); 2018 Jan; 34(1):24-26. PubMed ID: 29384090
[No Abstract] [Full Text] [Related]
16. Irradiation Decreases the Neuroendocrine Biomarker Pro-Opiomelanocortin in Small Cell Lung Cancer Cells In Vitro and In Vivo.
Meredith SL; Bryant JL; Babur M; Riddell PW; Behrouzi R; Williams KJ; White A
PLoS One; 2016; 11(2):e0148404. PubMed ID: 26848743
[TBL] [Abstract][Full Text] [Related]
17. The Notch ligand delta-like 3 promotes tumor growth and inhibits Notch signaling in lung cancer cells in mice.
Deng SM; Yan XC; Liang L; Wang L; Liu Y; Duan JL; Yang ZY; Chang TF; Ruan B; Zheng QJ; Han H
Biochem Biophys Res Commun; 2017 Jan; 483(1):488-494. PubMed ID: 28007595
[TBL] [Abstract][Full Text] [Related]
18. Blocking the NOTCH pathway can inhibit the growth of CD133-positive A549 cells and sensitize to chemotherapy.
Liu J; Mao Z; Huang J; Xie S; Liu T; Mao Z
Biochem Biophys Res Commun; 2014 Feb; 444(4):670-5. PubMed ID: 24502949
[TBL] [Abstract][Full Text] [Related]
19. Challenging the recalcitrant disease-developing molecularly driven treatments for small cell lung cancer.
Mak DWS; Li S; Minchom A
Eur J Cancer; 2019 Sep; 119():132-150. PubMed ID: 31445197
[TBL] [Abstract][Full Text] [Related]
20. Developmental signalling pathways in lung cancer.
Daniel VC; Peacock CD; Watkins DN
Respirology; 2006 May; 11(3):234-40. PubMed ID: 16635080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
